September 8, 2015
Yoshiaki Kamoya, Chairman, FPMAJ NHI Drug Pricing Study Committee The pharmaceutical industry should get together to discuss the future of drug pricing rules and other industrial policies and decide on “what to defend and what to give up,” says Yoshiaki...read more